Advertisement
Screener

ALPINE IMMUNE SCIENCES, INC. Patents: Applications Pending, 2023

ALPINE IMMUNE SCIENCES, INC. Patent Applications Pending

11 applications still open at the USPTO, newest filing first, as the USPTO Open Data Portal records them; the company is the first-named applicant. The application number opens the full record at Patent Center.

  • 2023-11-06: Application 18289746; Invention METHODS OF DOSING AND TREATMENT WITH A TACI-FC FUSION IMMUNOMODULATORY PROTEIN; Applicant Alpine Immune Sciences, Inc.; Status Non Final Action Mailed.
  • 2023-10-03: Application PCTUS2023075875; Invention METHODS AND USES OF TACI-FC FUSION IMMUNOMODULATORY PROTEIN; Applicant ALPINE IMMUNE SCIENCES, INC.; Status RO PROCESSING COMPLETED-PLACED IN STORAGE.
  • 2023-09-08: Application 63581609; Invention METHODS AND USES OF TACI-FC FUSION IMMUNOMODULATORY PROTEIN; Applicant Alpine Immune Sciences, Inc.; Status Provisional Application Expired.
  • 2023-05-30: Application 63505053; Invention METHODS AND USES OF TACI-FC FUSION IMMUNOMODULATORY PROTEIN; Applicant Alpine Immune Sciences, Inc.; Status Provisional Application Expired.
FiledApplicationInventionApplicantStatusPublished asInventor nameInventor countryExaminer
2023-11-0618289746METHODS OF DOSING AND TREATMENT WITH A TACI-FC FUSION IMMUNOMODULATORY PROTEINAlpine Immune Sciences, Inc.Non Final Action MailedUS20240279310A1
Stacey DILLON
Jing YANG
Stanford L. PENG
United States
United States
United States
ORWIG, KEVIN S
2023-10-03PCTUS2023075875METHODS AND USES OF TACI-FC FUSION IMMUNOMODULATORY PROTEINALPINE IMMUNE SCIENCES, INC.RO PROCESSING COMPLETED-PLACED IN STORAGE
STANFORD L. PENG
STACEY DILLON
JING YANG
RUPERT DAVIES
United States
United States
United States
United States
2023-09-0863581609METHODS AND USES OF TACI-FC FUSION IMMUNOMODULATORY PROTEINAlpine Immune Sciences, Inc.Provisional Application Expired
Stanford L. PENG
Stacey DILLON
Jing YANG
Rupert DAVIES
United States
United States
United States
United States
2023-05-3063505053METHODS AND USES OF TACI-FC FUSION IMMUNOMODULATORY PROTEINAlpine Immune Sciences, Inc.Provisional Application Expired
Stanford L. PENG
Stacey DILLON
Jing YANG
Rupert DAVIES
United States
United States
United States
United States
2023-05-1663502611METHODS AND USES OF TACI-FC FUSION IMMUNOMODULATORY PROTEINAlpine Immune Sciences, Inc.Provisional Application Expired
Stanford L. PENG
Stacey DILLON
Jing YANG
Rupert DAVIES
United States
United States
United States
United States
2023-04-2163497691METHODS AND USES OF TACI-FC FUSION IMMUNOMODULATORY PROTEINAlpine Immune Sciences, Inc.Provisional Application Expired
Stanford L. PENG
Stacey DILLON
Jing YANG
Rupert DAVIES
United States
United States
United States
United States
2023-03-2163491526METHODS AND USES OF TACI-FC FUSION IMMUNOMODULATORY PROTEINAlpine Immune Sciences, Inc.Provisional Application Expired
Stanford L. PENG
Stacey DILLON
Jing YANG
Rupert DAVIES
United States
United States
United States
United States
2023-03-1018182308CD80 VARIANT IMMUNOMODULATORY PROTEINS AND USES THEREOFAlpine Immune Sciences, Inc.Response to Non-Final Office Action Entered and Forwarded to ExaminerUS20240002466A1
Ryan Swanson
Michael Kornacker
Mark F. Maurer
Dan Ardourel
Daniel William Demonte
Joseph L. Kuijper
United States
United States
United States
United States
United States
United States
MOSELEY II, NELSON B
2023-03-06PCTUS2023063809IMMUNOMODULATORY PROTEINS OF VARIANT CD80 POLYPEPTIDES, CELL THERAPIES THEREOF AND RELATED METHODS AND USESALPINE IMMUNE SCIENCES, INC.RO PROCESSING COMPLETED-PLACED IN STORAGE
MARK F. MAURER
DANIEL WILLIAM DEMONTE
United States
United States
2023-02-2463486946METHODS AND USES OF TACI-FC FUSION IMMUNOMODULATORY PROTEINAlpine Immune Sciences, Inc.Provisional Application Expired
Stanford L. PENG
Stacey DILLON
Jing YANG
United States
United States
United States
2023-02-0863483936METHODS AND USES OF TACI-FC FUSION IMMUNOMODULATORY PROTEINAlpine Immune Sciences, Inc.Provisional Application Expired
Stanford L. PENG
Stacey DILLON
Jing YANG
United States
United States
United States